CEACAM5 and neoplasm: Some established circulating tumor-specific biomarkers, such as carcinoembryonic antigen (CEA), carbohydrate antigen (CA)242, CA724, and serum pepsinogen (SPG), are known to be of limited use in the diagnosis of GC 165.